• Unite Acquisition 1 posted a net loss of $1.21 million for the quarter ended June 30, 2026, narrowing 21% year over year.
• Operating loss improved 21% to $1.2 million as operating expenses fell 21% to $1.2 million.
• R&D expense dropped 59% to $138,167 on lower assay development, Duke sponsored research, tox study and packaging costs.
• G&A costs declined 10% to $1.06 million as lower professional fees offset higher compensation, including stock-based pay.
• Cash and cash equivalents rose to $670,488 at June 30, 2026; management flagged substantial doubt about funding the next 12 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Unite Acquisition 1 Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-089081), on August 13, 2026, and is solely responsible for the information contained therein.